Hadrian Szpurka

3.3k citations

35 papers · 2.0k indexed · h-index 17

Co-authors: Jaroslaw P. Maciejewski Hideki Makishima Michael A. McDevitt Ramón V. Tiu Mikkael A. Sekeres Christine L. O’Keefe Eric D. Hsi Anna Jankowska
Topics: Acute Myeloid Leukemia Research (22 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers)Chronic Myeloid Leukemia Treatments (9 papers)
Cited by: Hematology Genetics Rheumatology
Journals: Journal of Clinical Oncology Blood PLoS ONE
Partner nations: United States Japan India

In The Last Decade

Hadrian Szpurka

34 papers receiving 1.9k citations

Peers

Countries citing papers authored by Hadrian Szpurka

Since Specialization

Citations

This map shows the geographic impact of Hadrian Szpurka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadrian Szpurka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadrian Szpurka more than expected).

Fields of papers citing papers by Hadrian Szpurka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadrian Szpurka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadrian Szpurka. The network helps show where Hadrian Szpurka may publish in the future.

Co-authorship network of co-authors of Hadrian Szpurka

This figure shows the co-authorship network connecting the top 25 collaborators of Hadrian Szpurka. A scholar is included among the top collaborators of Hadrian Szpurka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadrian Szpurka. Hadrian Szpurka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms 2013 ·Leukemia ·Fabı́ola Traina,Valeria Visconte,Paul Elson,Ali Tabarroki,Ania Jankowska,Edy Hasrouni,Yuka Sugimoto,Hadrian Szpurka,Hideki Makishima,C. O'Keefe,Mikkael A. Sekeres,Anjali S. Advani,(unknown),Edward A. Copelan,Yogen Saunthararajah,Sara Teresinha Olalla Saad,J. Maciejewski,Ramón V. Tiu	219
2	Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide 2012 ·Journal of Hematology & Oncology ·Yuka Sugimoto,Mikkael A. Sekeres,Hideki Makishima,Fabı́ola Traina,Valeria Visconte,Anna Jankowska,Andrés Jerez,Hadrian Szpurka,Christine L. O’Keefe,Kathryn M Guinta,Manuel Afable,Ramón V. Tiu,Kathy L. McGraw,Alan F. List,Jaroslaw P. Maciejewski	18
3	Mutational Determinants of Epigenetic Instablity in Myeloid Malignancies 2012 ·Seminars in Oncology ·A. Jankowska,Hadrian Szpurka	2
4	CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors 2012 ·Leukemia ·Hideki Makishima,Yuka Sugimoto,Hadrian Szpurka,Michael J. Clemente,Kwok Peng Ng,Hideki Muramatsu,C. O'Keefe,Yogen Saunthararajah,Jaroslaw P. Maciejewski	14
5	Loss of expression of neutrophil proteinase-3: a factor contributing to thrombotic risk in paroxysmal nocturnal hemoglobinuria 2011 ·Haematologica ·Ania Jankowska,Hadrian Szpurka,Maria Grazia Calabró,Sanjay Mohan,Andrew E. Schade,Michael J. Clemente,Roy L. Silverstein,J. Maciejewski	9
6	Molecular lesions in childhood and adult acute megakaryoblastic leukaemia 2011 ·British Journal of Haematology ·Asahito Hama,Hideki Muramatsu,Hideki Makishima,Yuka Sugimoto,Hadrian Szpurka,Monika Jasek,Christine L. O’Keefe,Yoshiyuki Takahashi,Hirotoshi Sakaguchi,Sayoko Doisaki,Akira Shimada,Nobuhiro Watanabe,Koji Kato,Hitoshi Kiyoi,Tomoki Naoe,Seiji Kojima,Jaroslaw P. Maciejewski	13
7	Impact of Molecular Mutations on Treatment Response to Hypomethylating Agents in MDS 2011 ·Blood ·Fabı́ola Traina,Anna Jankowska,Valeria Visconte,Yuka Sugimoto,Hadrian Szpurka,Hideki Makishima,Andrés Jerez,Christine L. O’Keefe,Mikkael A. Sekeres,Anjali S. Advani,Yogen Saunthararajah,Matt Kalaycio,Edward A. Copelan,Sara T. Olalla Saad,Jaroslaw P. Maciejewski,Ramón V. Tiu	19
8	Consequences of UTX Dysfunction in Myelodysplastic Syndrome 2011 ·Blood ·A. Jankowska,Hadrian Szpurka,Venugopalan Cheriyath,Kwok Peng Ng,Zhenbo Hu,Michael A. McDevitt,Yogen Saunthararajah,Jaroslaw P. Maciejewski	1
9	Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations 2010 ·Leukemia Research ·Hadrian Szpurka,Anna Jankowska,Hideki Makishima,Juraj Bodo,Nelli Bejanyan,Eric D. Hsi,Mikkael A. Sekeres,Jaroslaw P. Maciejewski	29
10	Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies 2009 ·Journal of Clinical Oncology ·Hideki Makishima,Heather Cazzolli,Hadrian Szpurka,Andrew Dunbar,Ramón V. Tiu,Jungwon Huh,Hideki Muramatsu,Christine L. O’Keefe,Eric D. Hsi,Ronald Paquette,Seiji Kojima,Alan F. List,Mikkael A. Sekeres,Michael A. McDevitt,Jaroslaw P. Maciejewski	150
11	Involvement of TET2 in Regulation of Epigenetic Silencing in MDS and Related Myeloid Malignancies. 2009 ·Blood ·Hadrian Szpurka,Anna Jankowska,Kwok Peng Ng,(unknown),Yogen Saunthararajah,Jaroslaw P. Maciejewski	3
12	250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl , in Myeloid Malignancies 2008 ·Cancer Research ·Andrew Dunbar,Lukasz P. Gondek,Christine L. O’Keefe,Hideki Makishima,(unknown),Hadrian Szpurka,Mikkael A. Sekeres,Xiaofei Wang,Michael A. McDevitt,Jaroslaw P. Maciejewski	223
13	Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F 2008 ·Human Pathology ·Sarah E. Gibson,Andrew E. Schade,Hadrian Szpurka,Beata Bąk,Jaroslaw P. Maciejewski,Eric D. Hsi	9
14	Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor‐deficient PIG‐A mutant cells 2008 ·British Journal of Haematology ·Hadrian Szpurka,Andrew E. Schade,Anna Jankowska,Jaroslaw P. Maciejewski	14
15	Bone Marrow Phospho-STAT5 Expression in Non-CML Chronic Myeloproliferative Disorders Correlates With JAK2 V617F Mutation and Provides Evidence of In Vivo JAK2 Activation 2007 ·The American Journal of Surgical Pathology ·Samer Aboudola,(unknown),Hadrian Szpurka,(unknown),Xiaoxian Zhao,Nichole Prescott,Raymond R. Tubbs,Jaroslaw P. Maciejewski,Eric D. Hsi	30
16	SNP Array Karyotyping Allows for the Detection of Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MPD 2007 ·PLoS ONE ·Lukasz P. Gondek,Andrew Dunbar,Hadrian Szpurka,Michael A. McDevitt,Jaroslaw P. Maciejewski	69
17	Hemochromatosis‐associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts 2007 ·American Journal of Hematology ·(unknown),Hadrian Szpurka,(unknown),(unknown),Karl S. Theil,Alan Lichtin,Mikkael A. Sekeres,Jaroslaw P. Maciejewski	26
18	Identification of the JAK2 V617F Mutation in Chronic Myeloproliferative Disorders Using FRET Probes and Melting Curve Analysis 2006 ·American Journal of Clinical Pathology ·Gurunathan Murugesan,Samer Aboudola,Hadrian Szpurka,(unknown),Jaroslaw P. Maciejewski,Raymond R. Tubbs,Eric D. Hsi	53
19	Dysfunction of Lipid Raft Microdomains and Defective Apoptotic Signal Transduction in PNH. 2006 ·Blood ·Hadrian Szpurka,Andrew E. Schade,Mahrukh K. Ganapathi,Jaroslaw P. Maciejewski	2
20	Presence of JAK2 Mutations in MDS/MPD-u WHO Classified Patients and Not Other Forms of MDS Suggests Their Derivation from Classical Myeloproliferative Syndrome. 2005 ·Blood ·Hadrian Szpurka,Ramón V. Tiu,Eric D. Hsi,Alan Lichtin,Mikkael A. Sekeres,Karl S. Theil,Jaroslaw P. Maciejewski	1

About Hadrian Szpurka

Hadrian Szpurka is a scholar working on Hematology, Genetics and Rheumatology, having authored 35 papers that have together received 2.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers) and Chronic Myeloid Leukemia Treatments (9 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (972 citations) and Rheumatology (206 citations). Hadrian Szpurka has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Jaroslaw P. Maciejewski, Hideki Makishima, Michael A. McDevitt, Ramón V. Tiu, Mikkael A. Sekeres, Christine L. O’Keefe, Eric D. Hsi, Anna Jankowska, Andrew Dunbar and A. Jankowska. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact